Ischemic Mitral Regurgitation

Chronic ischemic MR develops well after the acute phase of myocardial infarction has passed, and is a genuinely different entity from the acute papillary muscle rupture covered on this section’s mechanical complications page — here, the valve itself is structurally intact, and the regurgitation comes entirely from geometry forced onto a normal valve by a damaged ventricle. See Mitral Regurgitation for the general secondary-MR mechanism and quantification framework this page builds directly on, adding the specific tethering patterns and measurements unique to the ischemic mechanism.

The Formal Classification: Carpentier Type IIIb

Mitral regurgitation is classified by leaflet motion using the Carpentier system, and chronic ischemic MR has a specific, formal designation worth knowing precisely: Type IIIb — restricted leaflet motion confined to systole. This is genuinely distinct from Type IIIa, where restriction occurs in both systole and diastole, from causes like rheumatic disease, toxic valvulopathy, or radiation-induced mitral valve disease.

The leaflets themselves are structurally normal in ischemic MR. The regurgitation arises entirely from malcoaptation forced by abnormal ventricular and papillary muscle geometry — not from any intrinsic disease of the leaflet tissue, annulus, or chordae. This is worth stating as the organizing fact behind everything else on this page: every measurement and pattern described below is really just quantifying how far normal leaflets have been pulled from their normal coaptation position.

Two Remodeling Patterns, Worth Assessing Separately

Ischemic MR’s tethering geometry splits cleanly into two patterns, and distinguishing them matters because they produce genuinely different leaflet deformation:

• Global remodeling — LV size, volume, overall systolic function, and sphericity index, the same geometric concept covered for dilated cardiomyopathy — typically from diffuse or anterior infarction. This produces symmetric tethering, pulling both leaflets toward the apex relatively evenly.
• Local remodeling — papillary muscle displacement and regional wall motion abnormality — typically from inferior or posterior infarction. This produces asymmetric tethering, since one papillary muscle (most often the posteromedial, given its single coronary supply) is displaced more than the other.

This distinction is worth cross-checking directly against the coronary territory already identified using the framework on Coronary Territories and Infarct Localization — an anterior-territory wall motion abnormality should raise suspicion for the global, symmetric pattern, while an inferior or posterior territory abnormality should raise suspicion for the local, asymmetric pattern instead.

The Measurements That Actually Quantify Tethering

Rather than describing tethering qualitatively, three specific geometric parameters quantify it directly:

• Tenting area (TA) — the area enclosed between the two leaflets and the mitral annular plane in systole, capturing how far the coaptation point has been pulled away from the annulus.
• Coaptation distance (CD) — the distance from the annular plane to the actual coaptation point.
• Posterolateral angle (PLA) — calculated as PLA = sin⁻¹(CD ÷ PLL), where PLL is posterior leaflet length, quantifying how sharply the posterior leaflet is angled away from its normal position.

Thresholds That Predict Repair Failure

These measurements carry real, actionable surgical-planning weight — each of the following is independently associated with a technically unfavorable mitral repair in secondary MR, worth stating explicitly in a report when ischemic MR is being evaluated for possible surgical correction:

Parameter	Unfavorable threshold
LV end-diastolic diameter	Over 65 mm
LV end-systolic diameter	Over 51 mm
Sphericity index	Over 0.7
Tenting area	2.5–3 cm² or more
Coaptation distance	1 cm or more
Posterolateral angle	Over 45°
Papillary muscle displacement	Severe apical and lateral displacement

A Genuine Diagnostic Trap: No Murmur in Half of Patients

No audible murmur is present in up to 50% of patients with significant ischemic MR — worth stating plainly as a genuine trap rather than a minor footnote, since the absence of a murmur can falsely reassure when regurgitation is actually present and hemodynamically significant. This follows directly from the Type IIIb mechanism itself: regurgitation here comes from a relatively subtle geometric malcoaptation on an otherwise normal valve, not from the kind of dramatic structural disruption (a flail leaflet, a ruptured chord) that reliably produces a loud, obvious murmur in primary valve disease. Auscultation is a correspondingly weaker screening tool for this specific entity, which is exactly why a wall motion abnormality in the right territory should prompt a deliberate, dedicated MR assessment regardless of what’s heard at the bedside.

Quantification: A Genuine PISA Pitfall Worth Knowing

Severity grading otherwise follows the same framework used for any secondary MR — see Mitral Regurgitation for the full quantitative approach and the lower severity thresholds that apply to secondary MR specifically. Two findings are worth knowing as genuinely specific to the ischemic mechanism:

• The regurgitant orifice is often ellipsoidal rather than circular, and can produce two separate jets originating from the medial and lateral ends of the coaptation line — a direct consequence of the asymmetric tethering pattern described above. The standard PISA method’s circular-orifice assumption can underestimate the true effective regurgitant orifice area in this setting, and 3D assessment should be considered whenever the calculated severity seems inconsistent with the broader clinical and structural picture.
• Effective regurgitant orifice area is dynamic in a specific, recognizable way: it characteristically decreases in mid-systole in secondary (including ischemic) MR — the opposite pattern from mitral valve prolapse, where EROA often appears or increases in mid-to-late systole instead. Tracking how regurgitant severity changes across the cardiac cycle, rather than measuring at a single moment, is itself a genuine clue to mechanism.

How to Approach Suspected Ischemic MR: A Practical Sequence

1. Don’t rely on auscultation to screen for this — actively assess the mitral valve in any patient with a regional wall motion abnormality, regardless of whether a murmur is present.
2. Determine whether the remodeling pattern is global or local by correlating LV size/sphericity with papillary muscle position and the specific coronary territory involved.
3. Measure tenting area, coaptation distance, and posterolateral angle explicitly rather than grading tethering severity by visual impression alone, particularly when mitral repair is being considered.
4. Quantify severity using the secondary-MR-specific thresholds, and consider 3D assessment specifically when the orifice appears ellipsoidal or when two distinct jets are seen on 2D color Doppler.
5. Track EROA across the cardiac cycle when the diagnosis or mechanism is genuinely ambiguous — a mid-systolic decrease supports the ischemic/secondary mechanism over prolapse.
6. Report the specific unfavorable-repair parameters explicitly when surgical referral is being considered, since these values directly inform the choice between repair and replacement.

Clinical Importance

Ischemic MR rewards understanding mechanism over pattern-matching to a murmur or a single severity grade — the same Type IIIb classification explains why it’s so often silent on exam, why its tethering geometry splits into two genuinely different patterns worth distinguishing, and why its PISA geometry can fool a quick 2D assessment. The tenting and repair-failure thresholds exist precisely because this is a condition where the decision to repair versus replace genuinely depends on geometry that can be measured, not just estimated.